Tim Lu Chief Medical Officer & Chief Scientific Officer | Tim has over 20 years of clinical, research and development experience. Prior to Candid, Tim was the Chief Medical Officer of DICE Therapeutics where he built and led the Development organization from when it was a private company, became a public company, and through the acquisition and integration by Eli Lilly and Company. As the CMO, he oversaw clinical development, development sciences, development operations, regulatory, program management, biometrics, pharmacovigilance, and quality. Prior to DICE, he led development of early stage programs in inflammatory bowel disease and other immunological indications at Genentech in Early Clinical Development OMNI. He was the therapeutic area lead for IBD. 

Prior to Genentech, Tim was at UCSF where he was an internal medicine resident, gastroenterology fellow, postdoctoral fellow, and assistant adjunct professor. Tim holds an M.D., Ph.D. degree from the University of Texas Southwestern Medical Center and B.S. in biology from Yale University.